Prenetics Global Limited Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
78.1%projected annual EPS growth
Analyst Coverage
5analysts covering
FY EPS (est.)
-$2.59next fiscal year
Monitoring Framework
Key Performance Indicators
IM8 Annualized Recurring Revenue (ARR) Monthly200MTarget: Maintain rapid growth trajectory to support FY2026 guidance
IM8 Segment Gross Margin Quarterly6,430.0%Target: Further expansion through manufacturing efficiencies
Total Adjusted Liquidity Quarterly139.7MTarget: Maintain strong balance sheet with zero debt
Watch Items
- IM8 Global Expansion and Subscriber GrowthTrigger: Subscription retention rates dropping below 80%Action: Re-evaluate celebrity-backed marketing campaigns and digital marketing spend optimization.
- Path to Profitability and EBITDA BreakevenTrigger: Adjusted EBITDA loss widening significantly beyond Q1 2026 levels of ($5.6M)Action: Implement AI-driven cost optimization and streamline operational expenses.
Research as of 20 Jun 2026